Stuart J. Swiedler

Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human α-L-iduronidase (laronidase)

J. E. Wraith, L. Clarke, Michael Beck et al. · The Journal of Pediatrics · 2004 · 546 citations

Life Sciences, Biochemistry, Enzymology +7

Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study

Paul Harmatz, Roberto Giugliani, Ida Vanessa Döederlein Schwartz et al. · The Journal of Pediatrics · 2006 · 364 citations

Life Sciences, Biochemistry, Pharmacotherapy +7

Carbohydrate ligands for endothelial-leukocyte adhesion molecule 1.

Michael Tiemeyer, Stuart J. Swiedler, Mayumi Ishihara et al. · Proceedings of the National Academy of Sciences · 1991 · 235 citations

Life Sciences, Biochemistry, Immunology +17

A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years

Monica Sifuentes, Robin Winkler Doroshow, Richard H. Hoft et al. · Molecular Genetics and Metabolism · 2006 · 219 citations

Life Sciences, Pharmacotherapy, Enzymology +4

Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase

Paul Harmatz, Roberto Giugliani, Ida Vanessa Döederlein Schwartz et al. · Molecular Genetics and Metabolism · 2008 · 216 citations

Life Sciences, Biochemistry, Clinical Biochemistry +8